1. Home
  2. PCRX vs BHRB Comparison

PCRX vs BHRB Comparison

Compare PCRX & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.96

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

HOLD

Current Price

$70.44

Market Cap

968.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
BHRB
Founded
2006
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
999.0M
968.8M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
PCRX
BHRB
Price
$25.96
$70.44
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$30.25
$71.80
AVG Volume (30 Days)
479.1K
169.9K
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
3.46%
EPS Growth
107.44
173.76
EPS
0.07
1.79
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$36.62
Revenue Next Year
$8.54
$10.06
P/E Ratio
$370.43
$39.54
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$56.35
52 Week High
$27.64
$73.69

Technical Indicators

Market Signals
Indicator
PCRX
BHRB
Relative Strength Index (RSI) 60.51 53.62
Support Level $21.89 $61.32
Resistance Level $26.94 $70.71
Average True Range (ATR) 0.82 1.60
MACD -0.03 -0.25
Stochastic Oscillator 56.59 38.57

Price Performance

Historical Comparison
PCRX
BHRB

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

Share on Social Networks: